Cosmos Health (NASDAQ:COSM) Trading Up 0.4% – Still a Buy?

Cosmos Health Inc. (NASDAQ:COSM)’s share price rose 0.4% during mid-day trading on Monday . The company traded as high as $0.3343 and last traded at $0.3262. Approximately 76,209 shares were traded during trading, a decline of 81% from the average daily volume of 399,749 shares. The stock had previously closed at $0.3249.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Cosmos Health Trading Up 0.6%

The company has a quick ratio of 0.84, a current ratio of 0.99 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $11.94 million, a price-to-earnings ratio of -0.43 and a beta of 5.39. The company has a 50-day moving average price of $0.39 and a 200-day moving average price of $0.62.

Insider Buying and Selling

In other Cosmos Health news, CEO Grigorios Siokas purchased 493,495 shares of the business’s stock in a transaction dated Wednesday, January 14th. The stock was bought at an average cost of $0.45 per share, for a total transaction of $222,072.75. Following the completion of the acquisition, the chief executive officer directly owned 7,738,474 shares in the company, valued at $3,482,313.30. This represents a 6.81% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last quarter, insiders purchased 2,145,143 shares of company stock valued at $982,154. Insiders own 25.10% of the company’s stock.

Hedge Funds Weigh In On Cosmos Health

Several large investors have recently bought and sold shares of the stock. XTX Topco Ltd boosted its holdings in Cosmos Health by 52.1% in the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after purchasing an additional 34,117 shares during the period. Renaissance Technologies LLC raised its position in shares of Cosmos Health by 260.5% during the fourth quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after buying an additional 241,775 shares during the last quarter. Finally, Citadel Advisors LLC lifted its stake in shares of Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after buying an additional 128,776 shares during the period. 12.61% of the stock is currently owned by institutional investors and hedge funds.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.